Earnings Feed
Start Free
Home/Filings/4/0000914190-16-000612
4//SEC Filing

Arno Therapeutics, Inc 4

Accession 0000914190-16-000612

CIK 0001195116operating
View on SEC.govCompany Profile

Filed

Apr 10, 8:00 PM ET

Accepted

Apr 11, 4:21 PM ET

Size

16.2 KB

Accession

0000914190-16-000612

Insider Transaction Report

Form 4
Period: 2016-04-07
Arno Therapeutics, IncARNI
Ruchefsky Steven B
Director
Transactions
  • Award

    Stock Option (right to buy)

    2016-04-07+88,628→ 88,628 total
    Exercise: $0.37Exp: 2026-04-07→ Common Stock (88,628 underlying)
Holdings

  • Stock Option (right to buy)

    Exercise: $8.00Exp: 2020-11-05→ Common Stock (3,750 underlying)
    3,750

  • Stock Option (right to buy)

    Exercise: $0.85Exp: 2024-11-04→ Common Stock (136,784 underlying)
    136,784

  • 2013 Series D Warrants (right to buy)

    (indirect: By LLC)
    Exercise: $2.14From: 2013-10-29Exp: 2018-10-29→ Common Stock (1,285,046 underlying)
    1,285,046

  • Common Stock

    (indirect: By LLC)
    4,472,905

  • Stock Option (right to buy)

    Exercise: $2.40Exp: 2023-11-04→ Common Stock (205,344 underlying)
    205,344

  • Stock Option (right to buy)

    Exercise: $2.90Exp: 2024-01-24→ Common Stock (34,224 underlying)
    34,224

  • 2012 Series A Warrants (right to buy)

    (indirect: By LLC)
    Exercise: $1.36From: 2013-10-29Exp: 2017-11-26→ Common Stock (1,531,861 underlying)
    1,531,861

  • Stock Option (right to buy)

    Exercise: $0.36Exp: 2025-11-04→ Common Stock (48,399 underlying)
    48,399
Footnotes (6)
  • [F1]The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  • [F2]Currently exerciseable.
  • [F3]Vests in equal 36-monthly installments commencing 12/4/13.
  • [F4]Vests in equal 36-monthly installments commencing 12/4/14.
  • [F5]Vests in equal 36-monthly installments commencing 12/4/15.
  • [F6]Vests in equal 12-monthly installments commencing 5/7/16.

Documents

1 file

Issuer

Arno Therapeutics, Inc

CIK 0001195116

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001195116

Filing Metadata

Form type
4
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 4:21 PM ET
Size
16.2 KB
View on SEC.gov